Clinical Diabetes found that people with type 1 diabetes can achieve positive results with new diabetes technology when trained by a primary care provider or through telehealth. Researchers from the ...

U-500 has prandial and basal time–action profile characteristics. d Basal insulin (glargine, detemir, or isophane [NPH]) may be substituted for bedtime U-500 insulin to adjust fasting blood ...

A basal, prandial, and bolus regimen is the ADA’s recommendation for noncritical hospital patients who have good nutritional intake. Continuous intravenous insulin infusions may be the most ...

Their results have now been published in Cancer Discovery. "Basal cell carcinoma is by far the most common skin cancer in humans," says Sánchez-Danés. "We all know people that have had one ...

Basal cell carcinomas (BCCs) are keratinocyte tumours that resemble the basal layer of the epidermis, and are the most commonly diagnosed human cancer among persons of European ancestry.

Expert Rev Endocrinol Metab. 2010;5(3):331-342. Metformin also forms the cornerstone of dual therapy and is used extensively in combination with several classes of OADs. The safety and efficacy of ...

For adults with type 1 diabetes, choosing a basal insulin analogue over neutral protamine Hagedorn and a rapid-acting prandial insulin analogue or inhaled insulin over regular human insulin will ...

1 Department of Clinical Sciences and Nutrition, The University of Chester, Chester, Cheshire, UK 2 Division of Nutritional Sciences, The University of Nottingham, Sutton Bonnington, Leicestershire, ...

Diabetes mellitus (DM) affects the metabolism of primary macronutrients such as proteins, fats, and carbohydrates. Due to the high prevalence of DM, emergency admissions for hyperglycemic crisis, ...

Conventional markers used for diagnosing and managing diabetes have recently come to question. This blog addresses some of these issues.  Fasting glucose levels may be misleading: The fasting glucose ...

Novo Nordisk’s bid to provide a once-weekly basal insulin product for people with diabetes, reducing the number of injections needed, has hit a major hurdle in the US. The FDA sent the Danish ...